Phospho-Site-Specific Antibody Microarray to Study the State of Protein Phosphorylation in the Retina
- PMID: 20151040
- PMCID: PMC2819533
- DOI: 10.4172/jpb.1000031
Phospho-Site-Specific Antibody Microarray to Study the State of Protein Phosphorylation in the Retina
Abstract
Neurodegeneration is an important component of diabetic retinopathy as demonstrated by increased neural apoptosis in the retina during experimental and human diabetes. Accumulation of sorbitol and fructose and the generation or enhancement of oxidative stress has been reported in the whole retina of diabetic animals. Aldose reductase (AR), the first and the rate limiting enzyme in the pathway reduces glucose to sorbitol and the diabetic complications are prevented by drugs that inhibit AR. In this study we examined the phosphorylation state of various retinal proteins in response to sorbitol-treatment by phosphor-site-specific antibody microarray. Our results suggest that various retinal protein kinases and cytoskeletal proteins either activated or down regulated in response to sorbitol treatment. Further, our study also indicates the activation of retinal insulin- and insulin growth factor 1 receptor and their downstream signaling proteins such as phosphoinositide 3-kinanse and protein kinase B (Akt). Understanding the regulation of retinal proteins involved in polyol (sorbitol) pathway would help to design therapeutic agents for the treatment of diabetic retinopathy.
Figures



Similar articles
-
Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.J Neurosci. 2021 Apr 7;41(14):3275-3299. doi: 10.1523/JNEUROSCI.2010-20.2021. Epub 2021 Feb 23. J Neurosci. 2021. PMID: 33622781 Free PMC article.
-
Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.Biochem Biophys Res Commun. 2002 Nov 29;299(2):183-8. doi: 10.1016/s0006-291x(02)02584-6. Biochem Biophys Res Commun. 2002. PMID: 12437967
-
In vitro retinal and erythrocyte polyol pathway regulation by hormones and an aldose reductase inhibitor.Diabetes Res Clin Pract. 1991 Oct;14(1):29-35. doi: 10.1016/0168-8227(91)90050-n. Diabetes Res Clin Pract. 1991. PMID: 1748061
-
The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient.Exp Diabetes Res. 2007;2007:61038. doi: 10.1155/2007/61038. Exp Diabetes Res. 2007. PMID: 18224243 Free PMC article. Review.
-
Aldose reductase / polyol inhibitors for diabetic retinopathy.Curr Pharm Biotechnol. 2011 Mar 1;12(3):373-85. doi: 10.2174/138920111794480642. Curr Pharm Biotechnol. 2011. PMID: 20939801 Review.
Cited by
-
Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy.Cell Death Discov. 2023 Nov 17;9(1):418. doi: 10.1038/s41420-023-01717-2. Cell Death Discov. 2023. PMID: 37978169 Free PMC article. Review.
-
New Approaches to Comparative and Animal Stress Biology Research in the Post-genomic Era: A Contextual Overview.Comput Struct Biotechnol J. 2014 Sep 30;11(19):138-46. doi: 10.1016/j.csbj.2014.09.006. eCollection 2014 Sep. Comput Struct Biotechnol J. 2014. PMID: 25408848 Free PMC article. Review.
References
-
- Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003;52:506–511. - PubMed
-
- Barber AJ, Nakamura M, Wolpert EB, Reiter CE, Seigel GM, Antonetti DA, Gardner TW. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem. 2001;276:32814–32821. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials